Skip to main content
Pharmena S.A. logo

Pharmena S.A. — Investor Relations & Filings

Ticker · PHR ISIN · PLPHRMN00011 LEI · 259400RHT936BBKW0955 WAR Manufacturing
Open in API
Filings indexed 649 across all filing types
Latest filing 2020-06-24 Board/Management Inform…
Country PL Poland
Listing WAR PHR

About Pharmena S.A.

https://www.pharmena.eu/

Pharmena S.A. is a specialty healthcare company focused on the development and commercialization of innovative products based on its patented active ingredient, 1-MNA. This molecule is a naturally occurring metabolite of niacin (vitamin B3) that plays a crucial role in cellular metabolism. The company's technology leverages the ability of 1-MNA to optimize the levels of the coenzyme NAD+, which decline with age and are vital for cellular function and regeneration. The product portfolio includes specialized cosmeceuticals, such as the Dermena line for hair loss, and dietary supplements designed to address the effects of cellular aging.

Recent filings

Filing Released Lang Actions
Informacja dot Jacka Szwajcowskiego
Board/Management Information Classification · 98% confidence The document is a formal disclosure written in Polish, detailing specific information about a member of the Supervisory Board ('Członek Rady Nadzorczej'), Mr. Jacek Szwajcowski. It explicitly references a specific regulation ('Rozporządzenia Ministra Finansów z dnia 29 marca 2018 roku') concerning current and periodic information disclosed by issuers of securities. The content covers appointment date, function, education, professional history, and other business activities, which is characteristic of disclosures related to the composition and changes within the management or supervisory body of a listed company. This aligns directly with the definition for Board/Management Information (MANG).
2020-06-24 Polish
Informacja dot Zbigniewa Molenda
Board/Management Information Classification · 95% confidence The document text is in Polish and details information about Mr. Zbigniew Molenda, a member of the Supervisory Board ('Członek Rady Nadzorczej'). It explicitly references a regulation from the Minister of Finance concerning current and periodic information disclosed by issuers of securities ('Informacje bieżące i okresowe przekazywane przez emitentów papierów wartościowych'). The content focuses on the appointment date, function, education, professional history, and other roles held by a director/executive. This structure strongly aligns with reporting requirements for insider transactions or changes in management/board composition. Since it details the personal and professional standing of a director, it fits the definition of Board/Management Information (MANG) or potentially Director's Dealing (DIRS) if it were about trades. Given the comprehensive biographical and functional details provided for a Supervisory Board member, MANG is the most appropriate classification, as it reports on the status of a key individual within the company's governance structure.
2020-06-24 Polish
Informacja dot Anny Sysy-Jedrzejowskiej
Board/Management Information Classification · 98% confidence The document is titled 'Informacje dotyczące Pani prof. n. med. Anny Sysy-Jędrzejowskiej - członka Rady Nadzorczej...' and details the appointment, function (Członek Rady Nadzorczej - Member of the Supervisory Board), professional background, and other activities of a specific individual serving on the company's supervisory board. This content directly relates to the composition and structure of the company's governance body. This aligns perfectly with the definition of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management, or detailed information about them. It is not an Annual Report (10-K), Earnings Release (ER), or a general regulatory filing (RNS), as it is highly specific to management/board composition.
2020-06-24 Polish
Informacja dot Jerzego Gebickiego
Board/Management Information Classification · 98% confidence The document is titled 'Informacje dotyczące Pana prof. dr hab. Jerzego Gębickiego – członka Rady Nadzorczej...' (Information regarding Mr. Prof. Dr. Jerzy Gębicki – member of the Supervisory Board...). It details the appointment date, name, function (Członek Rady Nadzorczej - Member of the Supervisory Board), professional background, and other activities of a specific member of the company's supervisory body. This content directly relates to changes or information concerning the board of directors or senior management, matching the definition for Board/Management Information (MANG). The document structure is a formal report detailing an individual's status on the board.
2020-06-24 Polish
Informacja dot Agnieszki Dziki
Board/Management Information Classification · 98% confidence The document text is a formal disclosure in Polish regarding a member of the Supervisory Board ('Członek Rady Nadzorczej'), Agnieszka Dziki. It details her appointment date, function, professional background, and potential conflicts of interest (other business activities). This type of disclosure, focusing on the qualifications, roles, and potential conflicts of management or supervisory board members, aligns directly with the scope of Board/Management Information (MANG). It is not an Annual Report (10-K), an Earnings Release (ER), or a general regulatory filing (RNS), but a specific announcement about a director's status.
2020-06-24 Polish
Informacja dot Jacka Dauenhauera
Board/Management Information Classification · 99% confidence The document is a formal disclosure in Polish regarding an individual, Jacek Dauenhauer, who is a member of the Supervisory Board ('Członek Rady Nadzorczej'). It details his appointment date, qualifications, professional history, and other roles held outside the issuer. This structure and content directly correspond to reporting requirements concerning changes or details about a company's board or senior management. This aligns perfectly with the definition for Board/Management Information (MANG). The reference to specific Polish ministerial regulations confirms its nature as a formal corporate disclosure about management personnel.
2020-06-24 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.